Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» German Panel Saw Little to No Added Benefit for Pfizer’s Eliquis
German Panel Saw Little to No Added Benefit for Pfizer’s Eliquis
German Panel Saw Little to No Added Benefit for Pfizer’s Eliquis
Submitted by
admin
on March 15, 2012 - 10:35am
Source:
Bloomberg
News Tags:
Pfizer
Germany
Eliquis
Bristol-Myers Squibb
Headline:
German Panel Saw Little to No Added Benefit for Pfizer’s Eliquis
Do Not Allow Advertisers to Use My Personal information
